Docebo (DCBO)
(Delayed Data from NSDQ)
$44.72 USD
+0.72 (1.64%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $44.71 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$44.72 USD
+0.72 (1.64%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $44.71 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth B Momentum B VGM
Zacks News
Docebo Inc. (DCBO) Stock Moves -0.13%: What You Should Know
by Zacks Equity Research
In the latest trading session, Docebo Inc. (DCBO) closed at $38.44, marking a -0.13% move from the previous day.
Docebo Inc. (DCBO) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Docebo Inc. (DCBO) delivered earnings and revenue surprises of 400% and 0.75%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Docebo (DCBO) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Docebo's (DCBO) fourth-quarter performance is expected to have gained from steady demand for its enterprise learnings solutions boosted by an expanding client base.
Clarivate PLC (CLVT) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Clarivate PLC (CLVT) delivered earnings and revenue surprises of 29.41% and 3.67%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Docebo Inc. (DCBO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Docebo Inc. (DCBO) closed the most recent trading day at $35.01, moving +0.89% from the previous trading session.
Docebo Inc. (DCBO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Docebo Inc. (DCBO) closed at $36.70, marking a +1.02% move from the previous day.
Docebo Inc. (DCBO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Docebo Inc. (DCBO) closed the most recent trading day at $37.44, moving +0.08% from the previous trading session.
Docebo Inc. (DCBO) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Docebo Inc. (DCBO) closed at $39.50, marking a -1.94% move from the previous day.
Docebo Inc. (DCBO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Docebo Inc. (DCBO) closed at $37.36, marking a +1.58% move from the previous day.
Docebo Inc. (DCBO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Docebo Inc. (DCBO) closed at $35.83, marking a +0.73% move from the previous day.
Docebo Inc. (DCBO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Docebo Inc. (DCBO) closed the most recent trading day at $35.21, moving -0.28% from the previous trading session.
New Strong Buy Stocks for December 29th
by Zacks Equity Research
SPNS, CRS, DHT, DCBO and ENTX have been added to the Zacks Rank #1 (Strong Buy) List on December 29, 2022.
Does Docebo Inc. (DCBO) Have the Potential to Rally 81% as Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at an 80.8% upside potential for Docebo Inc. (DCBO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
New Strong Buy Stocks for November 22nd
by Zacks Equity Research
DCBO, APPF, AMEH, FUTU and ZEUS have been added to the Zacks Rank #1 (Strong Buy) List on November 22, 2022.
Docebo Inc. (DCBO) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Docebo Inc. (DCBO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Wall Street Analysts Predict an 114% Upside in Docebo Inc. (DCBO): Here's What You Should Know
by Zacks Equity Research
The mean of analysts' price targets for Docebo Inc. (DCBO) points to an 113.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Docebo Inc. (DCBO) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Docebo Inc. (DCBO) delivered earnings and revenue surprises of 300% and 2.09%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
ON24 (ONTF) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
ON24 (ONTF) delivered earnings and revenue surprises of 56.25% and 0.33%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
KORE Group Holdings, Inc. (KORE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
KORE Group Holdings, Inc. (KORE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Docebo Inc. (DCBO) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Docebo Inc. (DCBO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Docebo Inc. (DCBO) Climb 131% to Reach the Level Wall Street Analysts Expect?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 131.2% in Docebo Inc. (DCBO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Docebo Inc. (DCBO) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Docebo Inc. (DCBO) delivered earnings and revenue surprises of 0% and 0.89%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Inseego (INSG) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Inseego (INSG) delivered earnings and revenue surprises of 18.18% and 1.12%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Will Docebo Inc. (DCBO) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Docebo Inc. (DCBO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Thermon Group (THR) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Thermon Group (THR) delivered earnings and revenue surprises of 177.78% and 26.54%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?